The Venus Times

Sign in Subscribe

Venus Remedies Limited

Venus Remedies Limited

Venus Remedies Ltd is a leading injectable manufacturer in the world. Having a presence in 75 countries, the company has nine globally benchmarked facilities apart from 11 overseas marketing offices.

Venus' Elores in Oman

Venus Remedies Unveils Flagship R&D Drug, Elores, in Oman

In a momentous move, Venus Remedies, a pioneer in the pharmaceutical industry, has announced the launch of its flagship Research & Development product, 'Elores', in the Sultanate of Oman. This groundbreaking product promises to set new standards in the antibiotic segment and showcases the company's relentless pursuit of innovative solutions in

Saransh Chaudhary - Venus Remedies - Pharma Bio World

Special Feature: Insights from Our CEO, VMRC, Mr. Saransh Chaudhary

We are thrilled to share that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies, has been prominently featured in the Anniversary Issue of the prestigious Pharma Bio World (PBW) magazine. Highlights from the feature: 1. Reimagining Business Models: The special edition delves deep into how industry leaders

MAs for Cancer Drugs for Venus Remedies

Venus Remedies Bags Four More Market Authorisations for Cancer Drugs!

Hot on the heels of our recent achievements, Venus Remedies is thrilled to announce yet another significant accomplishment. We have secured market authorisations for our pioneering cancer drugs from the Philippines, Paraguay, Georgia, and Moldova. This new stride not only reinforces our commitment to spearheading global oncology solutions but also

Venus' Oncology Drugs Grabs The Oman, Malaysia, Bosnia, and Trinidad & Tobago Markets

Expanding Our Oncology Wing: Four Major Market Approvals

We're thrilled to announce that Venus Remedies has achieved a significant milestone in our commitment to providing top-tier oncology solutions worldwide. 🔹 Key Highlights: 1. Marketing Approvals from Four Key Markets: We have secured marketing approvals for our chemotherapy drugs from Oman, Malaysia, Bosnia, and Trinidad & Tobago. 2. These approvals mark

Saransh Chaudhary's Insights on AMR features in Business World

Saransh Chaudhary, President, GCC & CEO, VMRC Shares Insights on Innovative R&D in Antibiotics with Business World

In the ever-evolving medical landscape, antibiotic resistance, known as Antimicrobial Resistance (AMR), poses one of the most significant global challenges. In a testament to Venus Remedies' commitment to pioneering advancements in medical science, our esteemed President of Global Critical Care, Mr. Saransh Chaudhary, was featured in Business World's edition dated

Venus Remedies Joint Managing Director | TheHealthSite.com

Meropenem: The Powerful Antibacterial Solution for Effective Treatment

Shining a spotlight on an essential antibacterial drug called Meropenem, which has revolutionized the field of medicine, this news piece brings forth a recently published article about Meropenem at TheHealthSite.com. It highlights the insightful information on the drug as shared by Dr. Manu Chaudhary, Director, Research, Venus Remedies. Meropenem,

Venus Remedies Limited Receiving MA for Meropenem from Spain

Venus Remedies Secures Marketing Authorization for Meropenem in Spain

Venus Remedies Ltd. recently received Marketing Authorization (MA) to market our generic antibiotic, Meropenem, in Spain. This significant achievement marks a major milestone for the organization and reinforces our commitment to providing high-quality healthcare solutions globally. The approval from the Spanish regulator is a testament to the rigorous research, development,